Skip to content
2000
image of Comparative Dissolution Study of Ciprofloxacin Hydrochloride-sustained Release Tablets by Using Carbopol-934 and Guar Gum Polymers

Abstract

Aims

This study aimed to identify the potential release of the drug from the tablet dosage form using Carbopol-934 and Guar Gum polymers at different concentration ratios.

Objective

The objective of this study was todetermine the cumulative percentage of ciprofloxacin hydrochloride released from different polymers.

Method

We formulated ciprofloxacin hydrochloride sustained-release tablets with Carbopol-934 and Guar gum using the wet granulation method.For the formulation of sustained-release ciprofloxacin hydrochloridetablets, both polymers were mixedin varying ratios. The tablets were examined for pre-formulation studies, including the angle of repose, bulk density, compressibility index, and physiological properties, such as variations in weight, friability, and drug content. For post-formulation studies, such as the study, the release of the drugs was evaluated in a phosphate buffer solution (pH 7.4) for 8 h. However, the physiological properties of ciprofloxacin hydrochloride tablets were limited due to their liberality.

Results

The tablets containing guar gum (Batches B-I and B-II) showed better drug content than other polymer-based batches, such as Carbopol-934 (Batch A-I, A-II) and a mixture of both polymer Carbopol-934 and Guar gum (Batch C-I, C-II). Sustained drug release was observed in the guar gum polymer-based tablets (Batch B-II). It was observed that the dissolution profile of ciprofloxacin hydrochloride tablets formed using different polymers showed an increase in the polymer ratio, which can be related to the increase in drug release.

Conclusion

From this study, we can conclude that the ciprofloxacin hydrochloride drug release percentage was maximum when guar gum polymer was used in the tablet dosage form.

Loading

Article metrics loading...

/content/journals/cam/10.2174/0126667312330882241017040502
2024-11-07
2025-02-20
Loading full text...

Full text loading...

References

  1. Kyriacos S.B. Boukarim C. Safi W. Mroueh M. Maroun A.B. El-Khoury G. Shehayeb R. In vitro testing of ciprofloxacin formulations and preliminary study on BCS biowaiver. Yao Wu Shi Pin Fen Xi 2009 17 2 10
    [Google Scholar]
  2. Henry D.C. Jr Bettis R.B. Riffer E. Haverstock D.C. Kowalsky S.F. Manning K. Hamed K.A. Church D.A. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin. Ther. 2002 24 12 2088 2104 10.1016/S0149‑2918(02)80099‑6 12581547
    [Google Scholar]
  3. Boerema J. Boll B. Muytjens H. Branolte J. Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections. J. Antimicrob. Chemother. 1985 16 2 211 217 10.1093/jac/16.2.211 2933381
    [Google Scholar]
  4. Al-Omar M.A. Ciprofloxacin: Physical profile. Profiles Drug Subst. Excip. Relat. Methodol. 2005 31 163 178 10.1016/S0099‑5428(04)31004‑X 22469040
    [Google Scholar]
  5. Hoffman A. Pharmacodynamic aspects of sustained release preparations. Adv. Drug Deliv. Rev. 1998 33 3 185 199 10.1016/S0169‑409X(98)00027‑1 10837659
    [Google Scholar]
  6. Sánchez-Lafuente C. Teresa Faucci M. Fernández-Arévalo M. Álvarez-Fuentes J. Rabasco A.M. Mura P. Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers. Int. J. Pharm. 2002 234 1-2 213 221 10.1016/S0378‑5173(01)00962‑0 11839452
    [Google Scholar]
  7. Savaşer A. Özkan Y. Işımer A. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Farmaco 2005 60 2 171 177 10.1016/j.farmac.2004.10.001 15752476
    [Google Scholar]
  8. Krishnaiah Y.S.R. Karthikeyan R.S. Gouri Sankar V. Satyanarayana V. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Release 2002 81 1-2 45 56 10.1016/S0168‑3659(02)00031‑7 11992677
    [Google Scholar]
  9. Abdullah S. Bani-Jaber A. Alhakamy N.A. Jamous Y.F. Al-Masud A.A. Marzoog Al-Sharafa M. Preparation and in vitro/in vivo characterization of sustained-release ciprofloxacin-carrageenan complex. Eur. J. Pharm. Biopharm. 2023 191 78 89 10.1016/j.ejpb.2023.08.012 37619955
    [Google Scholar]
  10. Khalid R. Nasiri M. Sarwar H. Yasmin R. Zaheer K. Anwer S. Fatima A. Influence of cellulose and acetate-based polymers on the release of ciprofloxacin hcl from extended release matrix tablets prepared by direct compression technique. Bull. Pharm. Sci. 2020 43 1 11 25 10.21608/bfsa.2020.93530
    [Google Scholar]
  11. Jayaselvi S. Formulation and evaluation of floating tablet formulation and evaluation of floating tablets of ciprofloxacin HCL PHARMACEUTICS J.K.K.MUNIRAJAH MEDICAL RESEARCH FOUNDATION
    [Google Scholar]
  12. De la Cruz Gómez A.V. Comparison between the dissolution profiles of prolonged-release ciprofloxacin tablets available in the Colombian market. J. Appl. Pharm. Sci. 2022
    [Google Scholar]
  13. Breda S.A. Jimenez-Kairuz A.F. Manzo R.H. Olivera M.E. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int. J. Pharm. 2009 371 1-2 106 113 10.1016/j.ijpharm.2008.12.026 19150493
    [Google Scholar]
  14. Verma R.K. Garg S. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. J. Pharm. Biomed. Anal. 2004 35 3 449 458 10.1016/j.jpba.2004.01.012 15137971
    [Google Scholar]
  15. Khan N.A. Khan A. Ullah R. Ullah M. Alotaibi A. Ullah R. Haider A. Preparation and characterization of hydrophilic polymer based sustained-release matrix tablets of a high dose hydrophobic drug. Polymers (Basel) 2022 14 10 1985 10.3390/polym14101985 35631868
    [Google Scholar]
  16. Nardi-Ricart A. Nofrerias-Roig I. Suñé-Pou M. Pérez-Lozano P. Miñarro-Carmona M. García-Montoya E. Ticó-Grau J.R. Insa Boronat R. Suñé-Negre J.M. InsaBoronat R, Suñé-Negre JM. Formulation of sustained release hydrophilic matrix tablets of tolcapone with the application of sedem diagram: influence of tolcapone’s particle size on sustained release. Pharmaceutics 2020 12 7 674 10.3390/pharmaceutics12070674 32708961
    [Google Scholar]
  17. Hirun N. Kraisit P. Drug-polymers composite matrix tablets: Effect of hydroxypropyl methylcellulose (hpmc) k-series on porosity, compatibility, and release behavior of the tablet containing a bcs class i drug. Polymers (Basel) 2022 14 16 3406 10.3390/polym14163406 36015661
    [Google Scholar]
  18. Zhang C. Shao H. Han Z. Liu B. Feng J. Zhang J. Zhang W. Zhang K. Yang Q. Wu S. Development and in vitro–in vivo correlation evaluation of IMM-H014 extended-release tablets for the treatment of fatty liver disease. Int. J. Mol. Sci. 2023 24 15 12328 10.3390/ijms241512328 37569704
    [Google Scholar]
  19. Serrano-Mora L.E. Zambrano-Zaragoza M.L. Mendoza-Muñoz N. Leyva-Gómez G. Urbán-Morlán Z. Quintanar-Guerrero D. Preparation of co-processed excipients for controlled-release of drugs assembled with solid lipid nanoparticles and direct compression materials. Molecules 2021 26 7 2093 10.3390/molecules26072093 33917445
    [Google Scholar]
  20. Fitzgerald A.J. Cole B.E. Taday P.F. Nondestructive analysis of tablet coating thicknesses using terahertz pulsed imaging. J. Pharm. Sci. 2005 94 1 177 183 10.1002/jps.20225 15761941
    [Google Scholar]
  21. Blanco M. Alcalá M. Content uniformity and tablet hardness testing of intact pharmaceutical tablets by near infrared spectroscopy. Anal. Chim. Acta 2006 557 1-2 353 359 10.1016/j.aca.2005.09.070
    [Google Scholar]
  22. Chatterjee A. Siarry P. Nonlinear inertia weight variation for dynamic adaptation in particle swarm optimization. Comput. Oper. Res. 2006 33 3 859 871 10.1016/j.cor.2004.08.012
    [Google Scholar]
  23. Seitz J.A. Flessland G.M. Evaluation of the physical properties of compressed tablets. I. Tablet hardness and friability. J. Pharm. Sci. 1965 54 9 1353 1357 10.1002/jps.2600540926 5881235
    [Google Scholar]
  24. Jakubowska E. Ciepluch N. Blend segregation in tablets manufacturing and its effect on drug content uniformity—A review. Pharmaceutics 2021 13 11 1909 10.3390/pharmaceutics13111909 34834324
    [Google Scholar]
  25. Amin Benbouras M. Petrisor A.I. Prediction of swelling index using advanced machine learning techniques for cohesive soils. Appl. Sci. (Basel) 2021 11 2 536 10.3390/app11020536
    [Google Scholar]
  26. Ganesh GN Sureshkumar R Jawahar N Senthil V Venkatesh DN Srinivas MS Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer. J Pharm Sci Res. 2010 2 6 360 368
    [Google Scholar]
  27. Shaikh M.V. Kala M. Nivsarkar M. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: Ex-vivo stability and in-vitro activity. Eur. J. Pharm. Sci. 2017 100 262 272 10.1016/j.ejps.2017.01.026 28126560
    [Google Scholar]
/content/journals/cam/10.2174/0126667312330882241017040502
Loading
/content/journals/cam/10.2174/0126667312330882241017040502
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test